MAGLi 432   Click here for help

GtoPdb Ligand ID: 12123

PDB Ligand
Compound class: Synthetic organic
Comment: MAGLi 432 is reported as a non-covalent, potent and selective inhibitor of monoacylglycerol lipase (MAGL; MGLL) [1-2]. It was designed as an anti-inflammatory modulator, that was proposed to reduce pools of arachidonic acid in the brain, leading to reduced cyclooxygenase-mediated prostaglandin production and prostaglandin-induced neuroinflammation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 32.78
Molecular weight 462.07
XLogP 4.83
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cccc(c1Br)C(=O)N1CCN2[C@@H](C1)CC[C@@H](C2)c1ccc(cc1)Cl
Isomeric SMILES [C@H]12CC[C@@H](CN1CCN(C2)C(=O)c1c(Br)c(OC)ccc1)c1ccc(Cl)cc1
InChI InChI=1S/C22H24BrClN2O2/c1-28-20-4-2-3-19(21(20)23)22(27)26-12-11-25-13-16(7-10-18(25)14-26)15-5-8-17(24)9-6-15/h2-6,8-9,16,18H,7,10-14H2,1H3/t16-,18+/m0/s1
InChI Key BKTASVDLNMGMFP-FUHWJXTLSA-N
References
1. Kemble A, Hornsperger B, Ruf I, Richter H, Benz J, Kuhn B, Heer D, Wittwer M, Engelhardt B, Grether U. (2022)
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature.
biorxiv, Preprint. DOI: 10.1101/2022.05.04.490688
2. Petersen A, Benz J, Grether U, Hornsperger B, Kocer B, Kuhn B, Richter H, Tsuchiya S, Qui Y, Chen R. (2019)
Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors.
Patent number: WO2019134985A1. Assignee: Hoffmann-La Roche. Priority date: 08/01/2018. Publication date: 11/07/2019.